Pancreatic cancer vaccine shows promise

Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Vaccine shows promise for treating pancreatic cancer, study shows
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
Could a personalized vaccine help fight pancreatic cancer?
"GMA" examines a preliminary study where a personalized mRNA vaccine showed promise in reducing the risk of pancreatic cancer returning after surgery.
Trial shows promise of mRNA vaccines in treating pancreatic cancer
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and chemotherapy in patients with pancreatic ductal adenocarcinoma.
Vaccine shows promise for pancreatic cancer, study finds
Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,
Nature3d
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer
Cancer vaccines must induce immune cells, called CD8 + T cells, that can recognize cancer cells over the long term. In pancreatic cancer, a common and deadly cancer, RNA vaccines that ...
AOL2d
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer ...
Pancreatic cancer vaccine shows promise, according to study
In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...
New Blood Test Could Detect Pancreatic Cancer Earlier
A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Axios Vitals on MSN2d
Oregon researchers develop new test for pancreatic cancer
Researchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...
I Went to the ER with an Anxiety Attack Before College Finals. The Same Day, Doctors Found Pancreatic Cancer (Exclusive)
Toni Bravo thought she was having an anxiety attack a couple weeks before finals at the University of Notre Dame last year.
Cancer Vaccines Market on Track for Major Expansion in the 7MM Amid Immunotherapy Advancements, Predicts DelveInsight
The cancer vaccine market is anticipated to experience substantial growth in the coming years. This growth is driven by the rising number of cancer diagnoses, heightened awareness of cancer vaccines, ...